EORTC-06992-LG

Trial 06992: Low dose Chlorambucil maintenance vs. no treatment following high-dose Chlorambucil induction in patients with advanced B-Chronic Lymphocytic Leukemia. A Randomized phase III study of the EORTC LG (CLL-3).
Trial StatusClosed for recruitment
DatesDate of activation: 14-Mar-01
Date Step1 close: 31-Oct-03
Date Step2 close: 01-Jun-04
Data management at EORTCFull
Phase3
Randomized trialYes
TypeHemato-malign
Targeted Sample size470
Number of steps2
DrugChlorambucil
Cyclophosphamide
Fludarabine
Study StaffMaura Brugiatelli (Study Coordinator) - Azienda Ospedaliera Papardo, Messina
Stefan Suciu (Statistician) - EORTC Headquarters, Brussels
Gaetan de Schaetzen (Project Manager) - EORTC Headquarters, Brussels, gaetan.deschaetzen( at )eortc.be, +32 27741618
Type of cancerChronic Lymphocytic Leukemia
Participating GroupsEORTC Leukemia Group(Coordinating Group)
Protocol summaryCancer.gov (PDQ)
ClinicalTrials.gov
NCT numberNCT00017108
EudraCT
Protocol documents in PDF
(requires password)
Study documentation
@
Back to Protocol section